85 related articles for article (PubMed ID: 25676888)
1. The effect of feeding on the pharmacokinetic variables of two commercially available formulations of omeprazole.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2015 Oct; 38(5):500-3. PubMed ID: 25676888
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
[TBL] [Abstract][Full Text] [Related]
3. The effects of dose and diet on the pharmacokinetics of omeprazole in the horse.
Sykes BW; Underwood C; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2017 Apr; 40(2):172-178. PubMed ID: 27478135
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral omeprazole in llamas.
Poulsen KP; Smith GW; Davis JL; Papich MG
J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.
Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
J Vet Pharmacol Ther; 2016 Feb; 39(1):78-83. PubMed ID: 25989292
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
[TBL] [Abstract][Full Text] [Related]
9. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
Thomson AB; Sinclair P; Matisko A; Rosen E; Andersson T; Olofsson B
Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
Hussein RF; Lockyer M; Hammami MM
Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of omeprazole powder paste or enteric-coated formulation in healing of gastric ulcers in horses.
Birkmann K; Junge HK; Maischberger E; Wehrli Eser M; Schwarzwald CC
J Vet Intern Med; 2014; 28(3):925-33. PubMed ID: 24628650
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and absolute bioavailability of lansoprazole.
Gerloff J; Mignot A; Barth H; Heintze K
Eur J Clin Pharmacol; 1996; 50(4):293-7. PubMed ID: 8803522
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.
Schaltenbrand R; Huber R; Cotoraci CA; Mascher H; Potthast H; Hole U
Int J Clin Pharmacol Ther; 2001 Oct; 39(10):453-9. PubMed ID: 11680670
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
[TBL] [Abstract][Full Text] [Related]
16. The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.
Podilsky G; Berger-Gryllaki M; Testa B; Buclin T; Roulet M; Pannatier A
Eur J Clin Pharmacol; 2009 May; 65(5):435-42. PubMed ID: 19189088
[TBL] [Abstract][Full Text] [Related]
17. Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.
Nieto JE; Spier S; Pipers FS; Stanley S; Aleman MR; Smith DC; Snyder JR
J Am Vet Med Assoc; 2002 Oct; 221(8):1139-43. PubMed ID: 12387383
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intrarectal omeprazole in alpacas.
Marmulak T; Stanley S; Kass PH; Wiebe V; McKemie D; Pusterla N
J Vet Pharmacol Ther; 2010 Aug; 33(4):371-5. PubMed ID: 20646199
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of the regulation of omeprazole in racehorses: An evidence-based approach.
Viljanto M; Hillyer L; Hincks P; Pearce C; Paine SW
J Vet Pharmacol Ther; 2018 Jun; 41(3):469-475. PubMed ID: 29468684
[TBL] [Abstract][Full Text] [Related]
20. Comparative bioavailability of two oral formulations of omeprazole.
Flores-Murrieta FJ; Carrasco-Portugal Mdel C; Reyes-García G; Medina-Santillán R; Herrera JE
Proc West Pharmacol Soc; 2009; 52():18-20. PubMed ID: 22128412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
